Use of illicit substances and violent behaviour in psychotic disorders: Two nationwide case-control studies and meta-analyses

J. Lamsma, W. Cahn, S. Fazel

Research output: Contribution to JournalArticleAcademicpeer-review

Abstract

Copyright © The Author(s) 2019.Background Substance use disorder explains much of the excess risk of violent behaviour in psychotic disorders. However, it is unclear to what extent the pharmacological properties and subthreshold use of illicit substances are associated with violence.Methods Individuals with psychotic disorders were recruited for two nationwide projects: GROUP (N = 871) in the Netherlands and NEDEN (N = 921) in the United Kingdom. Substance use and violent behaviour were assessed with standardized instruments and multiple sources of information. First, we used logistic regression models to estimate the associations of daily and nondaily use with violence for cannabis, stimulants, depressants and hallucinogens in the GROUP and NEDEN samples separately. Adjustments were made for age, sex and educational level. We then combined the results in random-effects meta-analyses.Results Daily use, compared with nondaily or no use, and nondaily use, compared with no use, increased the pooled odds of violence in people with psychotic disorders for all substance categories. The increases were significant for daily use of cannabis [pooled odds ratio (pOR) 1.6, 95% confidence interval (CI) 1.2-2.0), stimulants (pOR 2.8, 95% CI 1.7-4.5) and depressants (pOR 2.2, 95% CI 1.1-4.5), and nondaily use of stimulants (pOR 1.6, 95% CI 1.2-2.0) and hallucinogens (pOR 1.5, 95% CI 1.1-2.1). Daily use of hallucinogens, which could only be analysed in the NEDEN sample, significantly increased the risk of violence (adjusted odds ratio 3.3, 95% CI 1.2-9.3).Conclusions Strategies to prevent violent behaviour in psychotic disorders should target any substance use.
Original languageEnglish
Pages (from-to)2028-2033
JournalPsychological Medicine
Volume50
Issue number12
DOIs
Publication statusPublished - 1 Sept 2020
Externally publishedYes

Funding

Financial support. GROUP was funded by the Geestkracht programme of The Netherlands Organisation for Health Research and Development (10-000-1001) and matching funds from the coordinating university medical centres (i.e. Academic Medical Centre, Maastricht University Medical Centre+, University Medical Centre Groningen, University Medical Centre Utrecht), their affiliated mental health centres (i.e. Altrecht, Arkin, Delta, Dimence, Dijk en Duin, Erasmus UMC, GGNet, GGZ Breburg, GGZ Centraal, GGZ Drenthe, GGZ Eindhoven en De Kempen, GGZ Friesland, GGZ inGeest, Mondriaan, GGZ Noord-Holland-Noord, GGZ Oost-Brabant, GGZ Overpelt, GGZ Rivierduinen, Lentis, Mediant GGZ, Met GGZ, Parnassia Psycho-Medical Centre, Psychiatric Centre Ziekeren, Psychiatric Hospital Sancta Maria, Public Centre for Mental Health Rekem, The Collaborative Antwerp Psychiatric Research Institute, Vincent van Gogh voor Geestelijke Gezondheid, Virenze riagg, University Psychiatric Centre Sint Jozef, Yulius, Zuyderland GGZ) and participating pharmaceutical companies (i.e. Lundbeck, AstraZeneca, Eli Lilly, Janssen Cilag). NEDEN was funded by the United Kingdom Department of Health and Social Care (PO261680). JL received funding from the Prins Bernhard Cultuurfonds and Dr Hendrik Muller Fonds. SF is funded by a Wellcome Trust Senior Research Fellowship in Clinical Science (202836/ Z/16/Z).

FundersFunder number
Erasmus UMC
Geestkracht programme of The Netherlands Organisation for Health Research and Development10-000-1001
Prins Bernhard Cultuurfonds
United Kingdom Department of Health and Social CarePO261680
University Medical Centre Groningen
University Medical Centre Utrecht
Wellcome Trust202836/ Z/16/Z

    Fingerprint

    Dive into the research topics of 'Use of illicit substances and violent behaviour in psychotic disorders: Two nationwide case-control studies and meta-analyses'. Together they form a unique fingerprint.

    Cite this